To target this new group of consumers, Nestl has created a new frozen-food brand, Vital Pursuit that will launch in the fall of 2024
Answers to the most common questions from patients in Las Vegas and across Nevada
An estimated 1 to 10 percent of tirzepatide users report noticeable thirst, though this number likely underrepresents reality because many people do not report mild symptoms to their healthcare provider
Expected indication launch timelines for selected pipeline candidates Pharmaceutical companies are investing significantly in oral GLP-1s
This article breaks down what the company offers, what the regulatory context looks like, what the terms actually say, and what you should verify before making any enrollment decision
Poly ADP-ribose polymerase-1 inhibition by 3-aminobenzamide recuperates HEI-OC1 auditory hair cells from blast overpressure-induced cell death